BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2021 6:36:58 AM | Browse: 861 | Download: 1635
 |
Received |
|
2020-08-29 04:01 |
|
Peer-Review Started |
|
2020-08-29 04:01 |
|
First Decision by Editorial Office Director |
|
2021-01-07 19:24 |
|
Return for Revision |
|
2021-01-07 19:24 |
|
Revised |
|
2021-01-19 03:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-01-29 06:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-02-26 03:26 |
|
Articles in Press |
|
2021-02-26 03:26 |
|
Edit the Manuscript by Language Editor |
|
2021-03-08 04:28 |
|
Typeset the Manuscript |
|
2021-03-24 06:11 |
|
Publish the Manuscript Online |
|
2021-03-25 06:36 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Functional maturation of immature β cells: A roadblock for a stem cell therapy to type 1 diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zi-Yi Sun, Ting-Yan Yu, Fang-Xu Jiang and Wei Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of China |
81471081 |
| Natural Science Foundation of Fujian Province, China |
2019J01010 |
| Xiamen Research Foundation for Science and Technology Project |
3502Z20194037 |
| Scientific Research Foundation for Advanced Talents, Xiang’an Hospital of Xiamen University |
PM201809170005 |
|
| Corresponding Author |
Wei Wang, MD, Doctor, Doctor, Department of Endocrinology, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, 2000 Xiang'an East Road, Xiang'an District, Xiamen 361101, Fujian Province, China. wwei19742007@hotmail.com |
| Key Words |
Stem cell therapy; Type 1 diabetes mellitus; β cell; Maturation |
| Core Tip |
Type 1 diabetes is a metabolic disease characterized by absolute lack of insulin. Current insulin replacement therapy supplies insulin in a non-physiological way and is associated with devastating complications. A diabetes stem cell therapy with insulin-producing β-like cells differentiated in vitro from human pluripotent stem cells has recently attracted great interest in the academic community and the general public. Though great progresses have been made, the β-like cells differentiated in vitro differentiation still have many defects. Here we summarize the latest knowledge on β-cell maturation in vivo and in vitro and the vital roles of key molecules in this process, in order to explore the current problems in a diabetes stem cell therapy. |
| Publish Date |
2021-03-25 06:36 |
| Citation |
Sun ZY, Yu TY, Jiang FX, Wang W. Functional maturation of immature β cells: A roadblock for a stem cell therapy to type 1 diabetes. World J Stem Cells 2021; 13(3): 193-207 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i3/193.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i3.193 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
